Effect of treatment with botulinum toxin on neurogenic blepharospasm.
- 22 June 1985
- Vol. 290 (6485), 1857-1859
- https://doi.org/10.1136/bmj.290.6485.1857
Abstract
Botulinum toxin type A creates temporary localised flaccid paralysis after injection into skeletal muscle. Thirty four patients with blepharospasm, of whom 28 also had the oromandibular dystonia syndrome, were treated with injections of botulinum toxin type A into the orbicularis oculi, and 28 showed functional improvement after the treatment. A high incidence of local side effects occurred, especially partial ptosis, which was well tolerated. There were no systemic side effects. The average period of relief was 2.5 months, increasing to 2.8 months after a second injection. Functional improvement was limited in patients with severe associated dystonia.This publication has 20 references indexed in Scilit:
- Treatment of Essential BlepharospasmAmerican Journal of Ophthalmology, 1984
- Blepharospasm associated with brainstem lesionsNeurology, 1983
- Blepharospasm and orofacial‐cervical dystonia: Clinical and pharmacological findings in 100 patientsAnnals of Neurology, 1983
- Choline for BlepharospasmNew England Journal of Medicine, 1981
- Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus SurgeryOphthalmology, 1980
- Pharmacology of blepharospasm‐oromandibular dystonia syndromeNeurology, 1980
- Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia?Journal of Neurology, Neurosurgery & Psychiatry, 1976
- An electron microscopic study of the changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouseJournal of the Neurological Sciences, 1971
- Changes in the electron microscopic structure of slow and fast skeletal muscle fibres of the mouse after the local injection of botulinum toxinJournal of the Neurological Sciences, 1971
- PHYSIOLOGY OF BOTULINUS TOXINArchives of Neurology & Psychiatry, 1947